Sommaire

• • ·Contents

    Page :A1

    
• • ·Editorial Board

    Page :A5

    
• • ·Information for Readers

    Page :A6

    

• Trial Design

  • ·Apixaban for Reduction In Stroke and Other ThromboemboLic Events in Atrial Fibrillation (ARISTOTLE) trial: Design and rationale

    Page :331-339

    Renato D. Lopes, John H. Alexander, Sana M. Al-Khatib, Jack Ansell, Raphael Diaz, J. Donald Easton, Bernard J. Gersh, Christopher B. Granger, Michael Hanna, John Horowitz, Elaine M. Hylek, John J.V. McMurray, Freek W.A. Verheugt, Lars Wallentin, on behalf of the ARISTOTLE Investigators

    Résumé Résumé Plan Plan  
  • ·Rivaroxaban—Once daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: Rationale and Design of the ROCKET AF study

    Page :340

    The Executive Steering Committee, on behalf of the ROCKET AF Study Investigators ? a

    Résumé Résumé Plan Plan  
  • ·Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment

    Page :348

    John W. Eikelboom, Martin O'Donnell, Salim Yusuf, Rafael Diaz, Greg Flaker, Robert Hart, Stefan Hohnloser, Campbell Joyner, Jack Lawrence, Prem Pais, Janice Pogue, David Synhorst, Stuart J. Connolly

    Résumé Résumé Plan Plan  
  • ·Rationale and design of Enhanced Angiogenic Cell Therapy in Acute Myocardial Infarction (ENACT-AMI): The first randomized placebo-controlled trial of enhanced progenitor cell therapy for acute myocardial infarction

    Page :354-360

    Monica Taljaard, Michael R. Ward, Michael J.B. Kutryk, David W. Courtman, Nancy J. Camack, Shaun G. Goodman, Thomas G. Parker, Alexander J. Dick, Jacques Galipeau, Duncan J. Stewart

    Résumé Résumé Plan Plan  
  • ·Rationale, design, and baseline data of the Japanese Primary Prevention Project (JPPP)—A randomized, open-label, controlled trial of aspirin versus no aspirin in patients with multiple risk factors for vascular events

    Page :361

    Tamio Teramoto, Kazuyuki Shimada, Shinichiro Uchiyama, Masahiro Sugawara, Yoshio Goto, Nobuhiro Yamada, Shinichi Oikawa, Katsuyuki Ando, Naoki Ishizuka, Tsutomu Yamazaki, Kenji Yokoyama, Mitsuru Murata, Yasuo Ikeda

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·In-hospital management of patients with atrial flutter

    Page :370-376

    Nancy M. Allen LaPointe, Jie-Lena Sun, Sigal Kaplan

    Résumé Résumé Plan Plan  
  • ·Evidence of disparity in the application of quality improvement efforts for the treatment of acute myocardial infarction: The American College of Cardiology's Guidelines Applied in Practice Initiative in Michigan

    Page :377-384

    Adesuwa B. Olomu, Mary Grzybowski, Vijay S. Ramanath, Adam M. Rogers, Bonnie Motyka Vautaw, Benrong Chen, Canopy Roychoudhury, Elizabeth A. Jackson, Kim A. Eagle, for the American College of Cardiology Foundation Guidelines Applied in Practice Steering Committee

    Résumé Résumé Plan Plan  
  • ·Variations in prevalent cardiovascular disease and future risk by metabolic syndrome classification in the REasons for Geographic And Racial Differences in Stroke (REGARDS) study

    Page :385-391

    Todd M. Brown, Jenifer H. Voeks, Vera Bittner, Monika M. Safford

    Résumé Résumé Plan Plan
  • ·Differences in mortality in acute coronary syndrome symptom clusters

    Page :392-398

    Barbara Riegel, Alexandra L. Hanlon, Sharon McKinley, Debra K. Moser, Hendrika Meischke, Lynn V. Doering, Patricia Davidson, Michele M. Pelter, Kathleen Dracup

    Résumé Résumé Plan Plan  
  • ·Cuff and aortic pressure differences during dobutamine infusion: A study of the effects of systolic blood pressure amplification

    Page :399-405

    Harold Smulyan, Ratnakar Mukherjee, Paul R. Sheehe, Michel E. Safar

    Résumé Résumé Plan Plan  
  • ·Relationships between emerging measures of heart failure processes of care and clinical outcomes

    Page :406-413

    Adrian F. Hernandez, Bradley G. Hammill, Eric D. Peterson, Clyde W. Yancy, Kevin A. Schulman, Lesley H. Curtis, Gregg C. Fonarow

    Résumé Résumé Plan Plan  
  • ·Myocardial structure and function by echocardiography in relation to glucometabolic status in elderly subjects from 2 population-based cohorts: A cross-sectional study

    Page :414

    Margret Leosdottir, Ronnie Willenheimer, Jonathan Plehn, Rasmus Borgquist, Petri Gudmundsson, Tamara B. Harris, Lenore J. Launer, Halldora Bjornsdottir, Peter M. Nilsson, Vilmundur Gudnason

    Résumé Résumé Plan Plan
  • ·Detection of elevated right atrial pressure using a simple bedside ultrasound measure

    Page :421-427

    Marc A. Simon, Dustin E. Kliner, John P. Girod, Diego Moguillansky, Flordeliza S. Villanueva, John J. Pacella

    Résumé Résumé Plan Plan  
  • ·Propranolol and the risk of hospitalized myopathy: Translating chemical genomics findings into population-level hypotheses

    Page :428-433

    Soko Setoguchi, John M. Higgins, Helen Mogun, Vamsi K. Mootha, Jerry Avorn

    Résumé Résumé Plan Plan
  • ·Clinical relevance of clopidogrel unresponsiveness during elective coronary stenting: Experience with the point-of-care Platelet Function Assay–100 C/ADP

    Page :434-438

    Catherine M. Moerenhout, Marc J. Claeys, Steven Haine, Hielko Miljoen, Johan M. Bosmans, Francine Vertessen, Katrien Kluppels, Marc Van der Planken, Christiaan J. Vrints

    Résumé Résumé Plan Plan
  • ·Mechanisms of nonfatal acute myocardial infarction late after stent implantation: The relative impact of disease progression, stent restenosis, and stent thrombosis

    Page :439-445

    Dimitrios Alexopoulos, Ioanna Xanthopoulou, Periklis Davlouros, Anastasia Damelou, Andreas Mazarakis, John Chiladakis, George Hahalis

    Résumé Résumé Plan Plan  
  • ·Does “late catch-up” exist in drug-eluting stents: Insights from a serial quantitative coronary angiography analysis of sirolimus versus paclitaxel-eluting stents

    Page :446

    Kyung Woo Park, Chi-Hoon Kim, Hae-Young Lee, Hyun-Jae Kang, Bon-Kwon Koo, Byung-Hee Oh, Young-Bae Park, Hyo-Soo Kim

    Résumé Résumé Plan Plan  
  • ·Long-term outcome of percutaneous catheter intervention for de novo coronary bifurcation lesions with drug-eluting stents or bare-metal stents

    Page :454-461

    Miroslaw Ferenc, Michael Gick, Rolf-Peter Kienzle, Hans-Peter Bestehorn, Klaus-Dieter Werner, Thomas Comberg, Min Zhao, Heinz Joachim Buettner, Franz-Josef Neumann

    Résumé Résumé Plan Plan  
  • ·Clopidogrel use and clinical events after drug-eluting stent implantation: Findings from the HealthCore Integrated Research Database

    Page :462

    John L. Petersen, John J. Barron, Bradley G. Hammill, Mark J. Cziraky, Kevin J. Anstrom, Peter M. Wahl, Eric L. Eisenstein, Mitchell W. Krucoff, Robert M. Califf, Kevin A. Schulman, Lesley H. Curtis

    Résumé Résumé Plan Plan  
  • ·Health-related quality of life and long-term mortality in patients treated with percutaneous coronary intervention

    Page :471-476

    Lisanne Schenkeveld, Susanne S. Pedersen, Josephine W.I. van Nierop, Mattie J. Lenzen, Peter P.T. de Jaegere, Patrick W. Serruys, Ron T. van Domburg

    Résumé Résumé Plan Plan  
  • ·Trends in echocardiography utilization in the Veterans Administration Healthcare System

    Page :477-483

    Kingston Okrah, Mary Vaughan-Sarrazin, Peter Cram

    Résumé Résumé Plan Plan  
  • ·Temporal trends in compliance with appropriateness criteria for stress single-photon emission computed tomography sestamibi studies in an academic medical center

    Page :484-489

    Raymond J. Gibbons, J. Wells Askew, David Hodge, Todd D. Miller

    Résumé Résumé Plan Plan  
  • ·Timing of nonemergent coronary artery bypass grafting and mortality after non-ST elevation acute coronary syndrome

    Page :490-496

    Marc W. Deyell, William A. Ghali, David B. Ross, Jianguo Zhang, Brenda R. Hemmelgarn, for the Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators

    Résumé Résumé Plan Plan  
  • ·Factors associated with cardiac conduction disorders and permanent pacemaker implantation after percutaneous aortic valve implantation with the CoreValve prosthesis

    Page :497-503

    Jan Baan, Ze Yie Yong, Karel T. Koch, José P.S. Henriques, Berto J. Bouma, Marije M. Vis, Riccardo Cocchieri, Jan J. Piek, Bas A.J.M. de Mol

    Résumé Résumé Plan Plan  

• Letters to the Editor

  • ·Effect of interval (V-V) optimization in ischemic versus nonischemic patients after cardiac resynchronization therapy

    Page :e11

    Fu Yi, Jin Yu, Bing Liu

    
  • ·Reply to the Letter to the Editor by Yi et al

    Page :e13

    Nina Ajmone Marsan, Jeroen J. Bax

    
  • ·Brain natriuretic peptide for cardiovascular events independent of left ventricular end-diastolic pressure

    Page :e15

    Viroj Wiwanitkit

    
  • ·Author response: B-type natriuretic peptide for cardiovascular events independent of left ventricular end-diastolic pressure

    Page :e17

    Kevin Rogers

    
  • ·Low vitamin D may explain the link between preeclampsia and cardiovascular disease

    Page :e19

    William B. Grant

    Plan Plan
  • ·“High-intensity interval training may reduce in-stent restenosis following percutaneous coronary intervention with stent implantation: A randomized controlled trial evaluating the relationship to endothelial function and inflammation.” Am Heart J 2009;158:734-41

    Page :e21

    Philippe Meyer, Mathieu Gayda, Éve Normandin, Thibaut Guiraud, Martin Juneau, Anil Nigam